Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1795 (LINC01795)
- Target
- LINC01795
- Molecular classification
- Other (long non-coding RNA, lncRNA)
01
Overview
Long intergenic non-protein coding RNA 1795 (LINC01795) is a human long non-coding RNA (lncRNA) gene located on chromosome 2 (58,275,532-58,297,857, forward strand)[3]. LINC01795 does not encode a protein but is classified as a long intergenic non-coding transcript[1][3]. LncRNAs such as LINC01795 are known to regulate gene expression through a variety of mechanisms including chromatin modification, acting as molecular scaffolds, or post-transcriptional regulation, although the specific biological functions and interacting partners of LINC01795 remain uncharacterized in public databases[1][3][7]. There are emerging links between long intergenic non-coding RNAs and diseases, particularly cancer and neurological disorders; LINC01795 has been mentioned among candidate risk genes for schizophrenia in some predictive genetic studies[4] and appears in genome-wide association studies for intergenic variants[5], but there is currently no evidence to support its use as a therapeutic target, biomarker, or drug interactor.
- Other names
- LINC01795long intergenic non-protein coding RNA 1795
02
Biological functions
Epigenetic regulation (inferred from general lincRNA function)[7]Gene expression modulation (inferred)[7]
03
Disease associations
Cancer (long intergenic non-coding RNAs, including LINC01795, have been implicated in cancer biology generally, specific roles for LINC01795 are largely uncharacterized but it is mentioned among risk genes in schizophrenia and may participate in cancer molecular signatures)[4][7]Neuropsychiatric disease (listed as a risk gene for schizophrenia)[4]
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 1795 (LINC01795).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1795 (LINC01795).